Precigen PGEN
NASDAQ PGEN
$7.18 +0.04 (+0.49%)
As of: Sep 4, 2026 · 3:18 PM EDT

Precigen (PGEN) Interest Expenses (2012 - 2026)

Precigen (PGEN) posted quarterly Interest Expenses of $2.9 million for Q1 2026, up 599.04% year-over-year from $416000.0 in Q1 2025, and up 11.55% quarter-over-quarter from $2.6 million in Q4 2025.

Analysis

Precigen (PGEN) Interest Expenses (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Interest Expenses for 15 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Expenses rose 599.04% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $8.6 million (up 135.56% YoY), while the FY2025 annual figure was $389.9 million, down 3.5% from the prior year.
  • Interest Expenses climbed to $2.9 million in Q1 2026 per PGEN's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $37.3 million in Q3 2025 and bottomed at -$1.4 million in Q4 2022.
  • Historically, Interest Expenses has averaged $3.7 million across 5 years, with a median of $1.3 million in 2025.
  • Annual changes were most pronounced in 2022 — Interest Expenses tumbled 112.14% — and 2025, when it soared 1866950.0%.
  • Precigen's Interest Expenses stood at -$1.4 million in 2022, then surged by 100.5% to $7000.0 in 2023, then soared by 37828.57% to $2.7 million in 2024, then dropped by 1.81% to $2.6 million in 2025, then increased by 11.55% to $2.9 million in 2026.
  • Business Quant data shows PGEN's Interest Expenses at $2.9 million in Q1 2026, $2.6 million in Q4 2025, and $37.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - 23.78 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 93.62 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 20.27 Mn
10 Precigen 2.56 Bn 2.56 Bn 52.17 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.95 Mn
Mar 31, 2026 2.91 Mn
Dec 31, 2025 2.96 Mn
Sep 30, 2025 902,000.00
Mar 31, 2025 1,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 136,000.00
Mar 31, 2023 324,000.00
Dec 31, 2022 637,000.00
Sep 30, 2022 2.04 Mn
Jun 30, 2022 2.06 Mn
Mar 31, 2022 2.04 Mn
Dec 31, 2021 4.85 Mn
Sep 30, 2021 4.77 Mn
Jun 30, 2021 4.63 Mn
Mar 31, 2021 4.54 Mn